Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s earnings beat ...

However, as Nvidia has shared the official specifications of the card, we have something that we can use the compare it against its predecessor on paper. *Includes trade-in value + $300 Samsung credit ...

The design of bathrooms has evolved considerably over the years, reflecting changes in fixtures, materials, aesthetics, spatial preferences, and development. One notable trend is the rise of the ...

The hepatitis B vaccine is a shot, typically injected into the arm, that protects against hepatitis B in babies, children, and adults. It is an important way to protect yourself and your children from ...

No, you’re not experiencing deja vu — the Galaxy S25 smartphones feel largely familiar on paper, as our comparison chart below illustrates. Outside the processor bump, the hardware differences ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...

Pharmaceutical company Moderna has been granted the funds to work on developing mRNA-based influenza vaccines, including for the strain causing the bird flu outbreak. Newsweek has contacted ...

Moderna Inc (NASDAQ:MRNA) stock is surging today, up 8.7% at $37.02 at last glance, after the vaccine maker was awarded $590 million from the U.S. Health and Human Services Department to speed up ...